SPINEMarketGroup

AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ExcelsiusHub™ navigation system. ExcelsiusHub™ joins the expansive ecosystem of Excelsius™ technologies and is designed to elevate the standard for freehand … [Read More...] about Globus Medical Launches ExcelsiusHub™ Navigation System

Mont Saint-Guibert, Belgium, November 20, 2024 – Novadip Biosciences, a clinical stage biotechnology company specializing in regenerative medicine, today announces approval from the US Food and Drug Administration (FDA) for its allogenic bone grafting material NVDX3 to enter an investigational new drug study (IND). NVDX3 is an allogenic bone grafting material forming a new class of regenerative … [Read More...] about Novadip’s NVDX3 reaches key milestones leading to IND approval from FDA to start phase 2b/3 study in cervical spine fusion

CHICAGO--(BUSINESS WIRE)--Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced FDA 510(k) clearance of a new registration method for its xvision Spine System®. The xvision CT-to-fluoroscopy (CT-Fluoro) registration method allows surgeons to navigate off a preoperative CT scan and fluoroscopic images from a standard 2D C-arm, eliminating the need for 3D intraoperative … [Read More...] about Augmedics Announces FDA Clearance, Completion of First Surgery for New CT-Fluoro Registration

Geneva, November 19, 2024 – Spineart, a leader in spine surgery innovation, today announces that it has reached the significant milestone of 100,000 Ti-LIFE Technology cages sold worldwide, supporting the Company’s mission to transform spine surgery for surgeons, patients and hospitals in more than 60 global markets. Launched in July 2016, Spineart’s Ti-LIFE Technology is based on a unique … [Read More...] about Spineart Celebrates 100,000 Ti-Life Technology Cages Sold Worldwide

GALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024. Key Highlights Financial ResultsMedtronic reported Q2 worldwide revenue of $8.403 billion, an increase of 5.3% as reported and 5.0% on an organic basis. Organic revenue growth comparison … [Read More...] about Medtronic reports second quarter fiscal 2025 financial results

REDWOOD CITY, Calif., Nov. 18, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new data in Medical Devices: Evidence and Research, which demonstrate the superiority of the Nevro1™ SI Joint Fusion System ("Nevro1"), a posterior integrated … [Read More...] about New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches

As spinal surgery techniques evolve, there’s a clear trend toward approaches that reduce recovery time, minimize tissue damage, and enhance patient outcomes. The Midline Pedicle Screws Approach (MPSA) exemplifies this shift by combining the structural benefits of traditional pedicle screw fixation with the advantages of minimally invasive surgery. The Midline Fixation Procedure is designed to … [Read More...] about (UPDATED 2024):+20 Midline Cortical Systems to Know…!

November 13, 2024 VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test that assists clinicians in the diagnosis of axial spondyloarthritis (axSpA). New Day Diagnostics in Knoxville, TN, … [Read More...] about Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis

Ecully, November 14, 2024 – 6 p.m.--Spineway: a week dedicated to medical excellence with more than 20 surgeons trained The Spineway Group, a , specialist in innovative implants for the treatment of severe spine disorders, organized a week of training dedicated to medical education from November 4 to 8, 2024. Through practical sessions in the operating room and on anatomical specimens in the … [Read More...] about Spineway : a week dedicated to medical excellence with more than 20 surgeons trained

SANTA CLARA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights (any comparisons are to the prior year period) Recent Operational Highlights (any comparisons are to the prior … [Read More...] about SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

Globus Medical is proud to introduce the ALLEGIANCE™ Retractor System, a groundbreaking ringless system designed to provide rigid and reliable access for anterior spine procedures. Created to meet the growing demands for precision and efficiency in the operating room, this system represents the latest advancement in Globus Medical’s commitment to improving surgical outcomes and enhancing the … [Read More...] about Globus Medical Launches the ALLEGIANCE™ Retractor System: A New Era in Anterior Spine Surgery

In a significant advancement for the field of radiology, the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RAI, an artificial intelligence (AI)-powered software designed to enhance the analysis of spine magnetic resonance imaging (MRI). Developed by Remedy Logic, this innovative program aims to improve both precision and efficiency in detecting degenerative pathology and … [Read More...] about FDA Clears New AI-Powered Spine MRI Software

Dallas, Tex. November 12, 2024 – Spineart, a leader in spine surgery innovation, unveils the Spineart Innovation Center in Dallas, Texas, with a grand opening date of Thursday, November 14, 2024. The Spineart Innovation Center is a 5,500-square-foot facility located at Trinity Towers. This state-of-the-art facility is designed for spine surgeons, hospitals, and academic institutions to enhance … [Read More...] about Spineart Announces the Opening of the Spineart Innovation Center in Dallas, Texas

Scottsdale, AZ – November 8, 2024--Foundation Surgical, an innovative leader in spinal implant technology, is thrilled to announce the US Food & Drug Administration (FDA) 510(k) clearance of its Vertiwedge® Intraosseous Device! This novel, motion-sparing partial vertebral body replacement device along with its Vertebral Body Osteotomy (VBO®) procedure is set to redefine the landscape of … [Read More...] about Foundation Surgical Unveils Revolutionary Motion Preservation Procedure with 510(k) Clearance

Nov. 7, 2023 — The field of medicine is undergoing rapid advancements, with artificial intelligence (AI) and machine learning (ML) opening new doors for patient care and clinical precision. In a groundbreaking initiative, Syntropiq has announced a partnership with the University of Jan Evangelista in Ústí nad Labem to embark on a long-term scientific research project aimed at revolutionizing … [Read More...] about Syntropiq and University of Jan Evangelista Join Forces on Pioneering AI Research in Surgery

WARSAW, Ind., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Recent Business … [Read More...] about OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance